Filing Details
- Accession Number:
- 0001179110-19-008351
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-02 16:01:40
- Reporting Period:
- 2019-07-01
- Accepted Time:
- 2019-07-02 16:01:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1477449 | Teladoc Health Inc. | TDOC | Services-Offices & Clinics Of Doctors Of Medicine (8011) | 043705970 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1726568 | Lewis Levy | C/O Teladoc Health, Inc. 2 Manhattanville Road, Suite 203 Purchase NY 10577 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-07-01 | 850 | $35.45 | 5,230 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2019-07-01 | 500 | $38.55 | 5,730 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-07-01 | 1,350 | $67.95 | 4,380 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-07-01 | 850 | $0.00 | 850 | $35.45 |
Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-07-01 | 500 | $0.00 | 500 | $38.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
33,853 | 2027-07-14 | No | 4 | M | Direct | |
41,000 | 2028-03-01 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2019.
- The option vests as to 25% of the shares on July 14, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
- The option vests as to 25% of the shares on March 1, 2019. The remainder of the shares vest in 36 equal monthly installments thereafter.